Evidence of autoinflammation as a principal mechanism of myocardial injury in SARS-CoV-2 PCR-positive medical examiner cases.
Autoinflammation
Coagulopathy
Complement
Heart
Myocarditis
Neutrophils
SARS-COV-2
Journal
Diagnostic pathology
ISSN: 1746-1596
Titre abrégé: Diagn Pathol
Pays: England
ID NLM: 101251558
Informations de publication
Date de publication:
18 Oct 2023
18 Oct 2023
Historique:
received:
26
07
2023
accepted:
27
09
2023
medline:
23
10
2023
pubmed:
19
10
2023
entrez:
18
10
2023
Statut:
epublish
Résumé
Disease from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) remains the seventh leading cause of death in the United States. Many patients infected with this virus develop later cardiovascular complications including myocardial infarctions, stroke, arrhythmia, heart failure, and sudden cardiac death (20-28%). The purpose of this study is to understand the primary mechanism of myocardial injury in patients infected with SARS-CoV-2. We investigated a consecutive cohort of 48 medical examiner cases who died with PCR-positive SARS-CoV-2 (COVpos) infection in 2020. We compared them to a consecutive cohort of 46 age- and sex-matched controls who were PCR-negative for SARS-CoV-2 (COVneg). Clinical information available at postmortem examination was reviewed on each patient. Formalin-fixed sections were examined using antibodies directed against CD42 (platelets), CD15 (myeloid cells), CD68 (monocytes), C4d, fibrin, CD34 (stem cell antigen), CD56 (natural killer cells), and myeloperoxidase (MPO) (neutrophils and neutrophil extracellular traps(NETs)). We used a Welch 2-sample T-test to determine significance. A cluster analysis of marker distribution was also done. We found a significant difference between COVpos and COVneg samples for CD42, CD15, CD68, C4d, fibrin, and MPO, all of which were significant at p < 0.001. The most prominent features were neutrophils (CD15, MPO) and MPO-positive debris suggestive of NETs. A similar distribution of platelets, monocytes, fibrin and C4d was seen in COVpos cases. Clinical features were similar in COVpos and COVneg cases for age, sex, and body mass index (BMI). These findings suggest an autoinflammatory process is likely involved in cardiac damage during SARS-CoV-2 infection. No information about clinical cardiac disease was available.
Sections du résumé
BACKGROUND
BACKGROUND
Disease from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) remains the seventh leading cause of death in the United States. Many patients infected with this virus develop later cardiovascular complications including myocardial infarctions, stroke, arrhythmia, heart failure, and sudden cardiac death (20-28%). The purpose of this study is to understand the primary mechanism of myocardial injury in patients infected with SARS-CoV-2.
METHODS
METHODS
We investigated a consecutive cohort of 48 medical examiner cases who died with PCR-positive SARS-CoV-2 (COVpos) infection in 2020. We compared them to a consecutive cohort of 46 age- and sex-matched controls who were PCR-negative for SARS-CoV-2 (COVneg). Clinical information available at postmortem examination was reviewed on each patient. Formalin-fixed sections were examined using antibodies directed against CD42 (platelets), CD15 (myeloid cells), CD68 (monocytes), C4d, fibrin, CD34 (stem cell antigen), CD56 (natural killer cells), and myeloperoxidase (MPO) (neutrophils and neutrophil extracellular traps(NETs)). We used a Welch 2-sample T-test to determine significance. A cluster analysis of marker distribution was also done.
RESULTS
RESULTS
We found a significant difference between COVpos and COVneg samples for CD42, CD15, CD68, C4d, fibrin, and MPO, all of which were significant at p < 0.001. The most prominent features were neutrophils (CD15, MPO) and MPO-positive debris suggestive of NETs. A similar distribution of platelets, monocytes, fibrin and C4d was seen in COVpos cases. Clinical features were similar in COVpos and COVneg cases for age, sex, and body mass index (BMI).
CONCLUSION
CONCLUSIONS
These findings suggest an autoinflammatory process is likely involved in cardiac damage during SARS-CoV-2 infection. No information about clinical cardiac disease was available.
Identifiants
pubmed: 37853435
doi: 10.1186/s13000-023-01397-7
pii: 10.1186/s13000-023-01397-7
pmc: PMC10585907
doi:
Substances chimiques
Fibrin
9001-31-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Circ Res. 2021 Apr 16;128(8):1214-1236
pubmed: 33856918
Int J Mol Sci. 2022 Feb 02;23(3):
pubmed: 35163638
Front Cardiovasc Med. 2022 Oct 14;9:1026866
pubmed: 36312241
Biostatistics. 2017 Jan;18(1):91-104
pubmed: 27445132
Am J Physiol Heart Circ Physiol. 2020 Nov 1;319(5):H1059-H1068
pubmed: 33036546
Future Cardiol. 2021 Oct;17(7):1277-1291
pubmed: 33739142
Clin Microbiol Infect. 2022 Aug;28(8):1066-1075
pubmed: 35339672
Curr Opin Cardiol. 2017 May;32(3):326-335
pubmed: 28212151
FASEB J. 2019 Feb;33(2):2171-2186
pubmed: 30252532
JACC Basic Transl Sci. 2022 Mar;7(3):294-308
pubmed: 35165665
Biometrika. 1947;34(1-2):28-35
pubmed: 20287819
Neurobiol Dis. 2021 Dec;161:105561
pubmed: 34780863
J Thorac Imaging. 2021 Mar 1;36(2):73-83
pubmed: 33306666
Heart. 2022 Dec 22;109(2):119-126
pubmed: 36280346
Nat Med. 2022 Mar;28(3):583-590
pubmed: 35132265
Medicine (Baltimore). 2022 Dec 9;101(49):e31540
pubmed: 36626452
Cells. 2020 Sep 29;9(10):
pubmed: 33003471
Circulation. 2006 Jan 31;113(4):593-5
pubmed: 16449736
J Exp Med. 2020 Jun 1;217(6):
pubmed: 32302401